Literature DB >> 22853814

Toll-like receptor signaling in liver ischemia and reperfusion.

Wilson J Chang1, Luis H Toledo-Pereyra.   

Abstract

Liver ischemia-reperfusion (I/R) injuries are significant clinical challenges implicated in various hepatic surgical procedures and transplantations. Associated with varying degrees of insult, the hallmark of I/R is the excessive inflammatory response potentiated by the host immune system. Toll-like receptors (TLRs), known to play an important role in pathogen-derived inflammation, are now thought to participate in I/R injury-derived inflammation signaling pathways. Endogenous particles (proteins, cytokines, nucleic acids) that are released from damaged host cells bind to TLR2, TLR4, and TLR9, resulting in even further injury by subsequent inflammatory reactions and activation of the innate immune system. This review aims to systematically examine the current literature about TLR signaling mechanisms, allowing for a greater understanding of the precise role of TLRs in hepatic I/R injuries.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22853814     DOI: 10.3109/08941939.2012.687802

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  16 in total

1.  Activation of c-Src: a hub for exogenous pro-oxidant-mediated activation of Toll-like receptor 4 signaling.

Authors:  Rajendra Karki; Yan Zhang; Orisa J Igwe
Journal:  Free Radic Biol Med       Date:  2014-03-15       Impact factor: 7.376

2.  Heme oxygenase-1 protects rat liver against warm ischemia/reperfusion injury via TLR2/TLR4-triggered signaling pathways.

Authors:  Han-Fei Huang; Zhong Zeng; Kun-Hua Wang; Hai-Yan Zhang; Shuai Wang; Wen-Xiang Zhou; Zhan-Bo Wang; Wang-Gang Xu; Jian Duan
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

3.  Role of ultrasound and microbubble-mediated heat shock protein 72 siRNA on ischemia-reperfusion liver injury in rat.

Authors:  Chungen Yan; Dongfang Zhu; Danwen Huang; Guoyuan Xia
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 4.  Inflammatory response to the ischaemia-reperfusion insult in the liver after major tissue trauma.

Authors:  Yang Li; Annette Palmer; Ludmila Lupu; Markus Huber-Lang
Journal:  Eur J Trauma Emerg Surg       Date:  2022-07-14       Impact factor: 2.374

5.  TLRs-JNK/ NF-κB Pathway Underlies the Protective Effect of the Sulfide Salt Against Liver Toxicity.

Authors:  Rania Abdel-Latif; Gehan Hussein Heeba; Soha Osama Hassanin; Shaimaa Waz; Amr Amin
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

Review 6.  TLR3 plays significant roles against hepatitis B virus.

Authors:  Masoud Karimi-Googheri; Mohammad Kazemi Arababadi
Journal:  Mol Biol Rep       Date:  2014-01-30       Impact factor: 2.316

Review 7.  Toll-like receptors in pathophysiology of liver diseases.

Authors:  Safak Kiziltas
Journal:  World J Hepatol       Date:  2016-11-18

8.  Positive Feedback Regulation between Transglutaminase 2 and Toll-Like Receptor 4 Signaling in Hepatic Stellate Cells Correlates with Liver Fibrosis Post Schistosoma japonicum Infection.

Authors:  Zhencheng Wen; Xiaofang Ji; Juanjuan Tang; Guiying Lin; Linzhuo Xiao; Cuiying Liang; Manni Wang; Fang Su; Dominique Ferrandon; Zi Li
Journal:  Front Immunol       Date:  2017-12-13       Impact factor: 7.561

9.  Role of warm ischemia on innate and adaptive responses in a preclinical renal auto-transplanted porcine model.

Authors:  Ludivine Rossard; Frédéric Favreau; Sebastien Giraud; Raphael Thuillier; Sylvain Le Pape; Jean Michel Goujon; Alexandre Valagier; Thierry Hauet
Journal:  J Transl Med       Date:  2013-05-24       Impact factor: 5.531

10.  Innate immunity activation involved in unprotected porcine auto-transplant kidneys preserved by naked caspase-3 siRNA.

Authors:  Cheng Yang; Long Li; Yinjia Xue; Zitong Zhao; Tian Zhao; Yichen Jia; Ruiming Rong; Ming Xu; Michael L Nicholson; Tongyu Zhu; Bin Yang
Journal:  J Transl Med       Date:  2013-09-13       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.